BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 1, 2026
Home » Topics » Coronavirus, Medical technology

Coronavirus, Medical technology
Coronavirus, Medical technology RSS Feed RSS

Other news to note for April 6, 2020

April 6, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bioivt, Bioreference Laboratories, Boston Heart Diagnostics, Carmat SA, Chandigarh University, Co-Diagnostics Inc., Deerfield Management, Itamar Medical Ltd., Luminex Corp., Mallinckrodt plc, Myriad Genetics, Inc., Nanomosaic, Nanostring, Openmed, Opko, Quotient, Safeguard Scientifics, Sano-Tek, Seaspine, Shockwave, Sleep Data Diagnostics, Synergy Laboratories, Theranica, Upscript.
Read More

BioWorld MedTech’s Cardiology Extra for April 6, 2020

April 6, 2020
By Liz Hollis
Keeping you up to date on recent developments in cardiology, including: Patient data registry aims to give insights for care, adverse cardiovascular outcomes; Research: Medicare changes could boost TAVR access; Muscle protein serves essential role in blood clotting during heart attack.
Read More
Canadian flag

Ottawa recruits Canadian equipment makers in CA$2B COVID-19 battle

April 3, 2020
By David Godkin
TORONTO – Canadian Prime Minister Justin Trudeau has yet to rule out following U.S. President Donald Trump’s lead by invoking his nation's wartime Defense Procurement Act compelling manufacturers to begin making ventilators to combat COVID-19. For now, Ottawa has signed contracts or letters of intent with eight equipment makers.
Read More
4-3-dunwoody-3d-shields.png

3D printing community rallies to meet hospitals’ needs in pandemic

April 3, 2020
By Meg Bryant
As health care workers face critical shortages of personal protective equipment (PPE) to deal with the COVID-19 crisis, 3D printing companies, medical device manufacturers and other organizations are stepping up to produce face shields, ventilators and other needed supplies. For its part, Rehovot, Israel-based Stratasys Ltd. has assembled a coalition of more than 150 companies and universities to produce 3D-printed visors and clear plastic face shields. The coalition aims to produce up to 16,000 face shields per week by the end of next week.
Read More
Telehealth illustration

FCC doubles down on existing telehealth pilot, draws raves from advocates

April 3, 2020
By Mark McCarty
The U.S. Federal Communications Commission (FCC) has received funds for another telehealth program in less than a year. An agency statement indicates that the program “would immediately support health care providers” working to thwart the COVID-19 outbreak. This would be achieved in part by supporting purchases of devices and other items needed to provide telehealth, which the Connected Health Initiative said will help drive an overdue overhaul of health care in the U.S.
Read More
Handshake, businessmen holding dollar sign, lightbulb

Med-tech deal and M&A values drop in Q1, significantly down from last year

April 3, 2020
By Karen Carey
A flurry of deal and M&A activity in the med-tech industry during the first quarter of 2020 has not translated into high financials, as many of the transactions are not disclosing terms. While the COVID-19 pandemic rages on, business development activities appear to be slumping in recent weeks, leaving the early part of the year significantly down from prior quarters.
Read More
Scientific data illustration
It’s not FAIR!

Accelerated by COVID-19, science changes will outlast pandemic

April 3, 2020
By Anette Breindl
COVID-19 has disrupted science in the way it has disrupted everything else. In the short term, universities have largely closed shop as a way to maximize social distancing, and lots of science – or at least, lots of bench work – is not getting done.
Read More

Regulatory front for April 3, 2020

April 3, 2020
The latest global regulatory news, changes and updates affecting medical devices and technologies.
Read More

Regulatory actions for April 3, 2020

April 3, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Becton Dickinson, Beroni Group, Biogx, Clinical Laserthermia Systems, Leica Biosystems.
Read More

Other news to note for April 3, 2020

April 3, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3M, Aperiomics, Astellas, Beroni Group, Buoy Health, Cigna, Dilon Technologies, Dune Medical Devices, Electrocore, Express Scripts, Foxo Bioscience, Horizon Discover, Insight Enterprises, Insurtech, Life Epigenetics, Mardill Medical, Nexstim, Novocure, Obviohealth, Pancella, Predictive Technology, Pinterest, Stimguard, Wellgistics, Yousurance.
Read More
Previous 1 2 … 161 162 163 164 165 166 167 168 169 … 184 185 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 30, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Roche identifies new TREM2 agonists

    BioWorld Science
    F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing